Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Eisai R&D Management Co Ltd | 13 |
| 2 | Rohto Pharmaceutical Co Ltd | 12 |
| 3 | Avedro Inc | 7 |
| 4 | Imperial Tobacco Ltd | 7 |
| 5 | Ajinomoto Co Inc | 6 |
| 6 | Resonac Holdings Corp | 6 |
| 7 | Daiichi Sankyo Healthcare Co Ltd | 4 |
| 8 | Eisai Co Ltd | 4 |
| 9 | Hisamitsu Pharmaceutical Co Inc | 4 |
| 10 | Chelsea Technologies Ltd | 3 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 54 |
| 2 | A61P | Therapeutic activity (drug indications) | 42 |
| 3 | C07D | Heterocyclic compounds | 24 |
| 4 | A23L | Foods and beverages (general) | 12 |
| 5 | G01N | Investigating / analysing materials | 12 |
| 6 | A23V | Foods, foodstuffs - indexing scheme | 11 |
| 7 | A61N | 8 | |
| 8 | A61Q | Cosmetics, personal care | 8 |
| 9 | A01N | Preservation of bodies; biocides; pest repellents | 6 |
| 10 | A24B | 6 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Photosynthetic Processes and Mechanisms | 11 |
| 2 | bioluminescence and chemiluminescence research | 11 |
| 3 | Amino Acid Enzymes and Metabolism | 8 |
| 4 | Enzyme Structure and Function | 6 |
| 5 | Pharmacogenetics and Drug Metabolism | 6 |
| 6 | Metabolism and Genetic Disorders | 4 |
| 7 | Nitric Oxide and Endothelin Effects | 4 |
| 8 | Polyamine Metabolism and Applications | 4 |
| 9 | Light effects on plants | 3 |
| 10 | Molecular Sensors and Ion Detection | 3 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Gordon Tollin | University of Arizona | 37 |
| 2 | Stephen G. Mayhew | University College Dublin | 35 |
| 3 | Adelbert Bacher | Technical University of Munich | 25 |
| 4 | Vincent Massey | University of Michigan | 21 |
| 5 | J. Woodland Hastings | Harvard University | 20 |
| 6 | Nigel S. Scrutton | University of Manchester | 18 |
| 7 | Changjian Feng | University of New Mexico | 17 |
| 8 | Donald B. McCormick | Cornell University | 16 |
| 9 | Franz Müller | Graduate School Experimental Plant Sciences | 14 |
| 10 | Andrew W. Munro | University of Strathclyde | 12 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure | 1999 | 3864 | Bacterial Genetics and Biotechnology |
| Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase | 1991 | 2363 | Nitric Oxide and Endothelin Effects |
| Purification and characterization of the flavoenzyme glutathione reductase from rat liver. | 1975 | 2021 | Redox biology and oxidative stress |
| <i>Shewanella</i> secretes flavins that mediate extracellular electron transfer | 2008 | 1971 | Electrochemical sensors and biosensors |
| Generation of reactive oxygen species by the mitochondrial electron transport chain | 2002 | 1240 | Alzheimer's disease research and treatments |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Riboflavin 5'-phosphate sodium?
Which organizations hold the most patents for Riboflavin 5'-phosphate sodium?
What research topics are most frequently associated with Riboflavin 5'-phosphate sodium in the literature?
What is the patent classification distribution for Riboflavin 5'-phosphate sodium?
How has patent and paper activity for Riboflavin 5'-phosphate sodium changed in recent years?